$7.3M Capital Raising
Filed with ASX · · 5 pages · English
• Firm commitments received for $2.5 million Placement to institutional and sophisticated investors • Launch of fully underwritten, non-renounceable, one (1) for six (6) Rights Issue to raise gross proceeds of approximately $4.8 million • Issue price for the Placement and the Rights Issue of $0.02, being a 4.8% discount to the most recent closing price and a 15.7% discount to the 15 day VWAP • One
Story so far
Earlier from Patrys
- Investor Presentation - November 2020 - Updated
- Investor Presentation - November 2020
- Appendix 4C - Quarterly - 30 September 2020
- First patent granted for Deoxymab-nanoparticles
- Patrys Adds Full Human Antibody to Deoxymab Portfolio
Later from Patrys
- Appendix 4C - Quarterly - 31 December 2020
- Patrys Successfully Establishes PAT-DX1 Stable Cell Line
- Appendix 4D - Half Year Accounts - 31 December 2020
- New United States patent granted for Patrys deoxymab assets
- Appendix 4C - Quarterly - 31 March 2021
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys